Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, P.O. Box 95500, 3508 GA Utrecht, The Netherlands.
Osteoarthritis Cartilage. 2010 May;18(5):605-12. doi: 10.1016/j.joca.2010.01.012. Epub 2010 Feb 6.
Molecules that are released into biological fluids during matrix metabolism of articular cartilage, subchondral bone, and synovial tissue could serve as biochemical markers of the process of osteoarthritis (OA). Unfortunately, actual breakthroughs in the biochemical OA marker field are limited so far.
By reviewing the status of commercially available biochemical OA markers according to the "Burden of disease, Investigative, Prognostic, Efficacy of intervention, and Diagnostic" ("BIPED") classification, future use of this "BIPED" classification is encouraged and more efficient biochemical OA marker research stimulated.
Three electronic databases [PubMed, Scopus, EMBASE (1997-May 2009)] were searched for publications on blood and urinary biochemical markers in human primary knee and hip-OA.
Stepwise selection of original English publications describing human studies on blood or urinary biochemical markers in primary knee or hip-OA was performed. Selected articles were fully read to determine whether biochemical markers were investigated on performance within any of the "BIPED" categories. Eighty-four relevant publications were identified.
Data from relevant publications were tabulated according to the "BIPED" classification. Individual analyses within a publication were summarized in general "BIPED" scores.
An uneven distribution of scores on biochemical marker performance and heterogeneity among the publications complicated direct comparison of individual biochemical markers. Comparison of categories of biochemical markers was therefore performed instead. In general, biochemical markers of cartilage degradation were investigated most extensively and performed well in comparison with other categories of biochemical markers. Biochemical markers of bone metabolism performed less adequately. Biochemical markers of synovial tissue metabolism were not investigated extensively, but performed quite well.
Specific biochemical markers and categories of biochemical markers as well as their nature, origin and metabolism, need further investigation. International standardization of future investigations should be pursued to obtain more high-quality, homogenous data on the full spectrum of biochemical OA markers.
在关节软骨、软骨下骨和滑膜组织的基质代谢过程中释放到生物体液中的分子可以作为骨关节炎(OA)过程的生化标志物。不幸的是,到目前为止,生化 OA 标志物领域的实际突破有限。
通过根据“疾病负担、调查、预后、干预效果和诊断”(“BIPED”)分类审查商业上可用的生化 OA 标志物的现状,鼓励未来使用这种“BIPED”分类,并刺激更有效的生化 OA 标志物研究。
三个电子数据库[PubMed、Scopus、EMBASE(1997 年-2009 年 5 月)]搜索了关于人类原发性膝关节和髋关节 OA 的血液和尿液生化标志物的出版物。
对描述原发性膝关节或髋关节 OA 血液或尿液生化标志物的原始英文出版物进行逐步选择。仔细阅读选定的文章,以确定是否在任何“BIPED”类别中对生化标志物的性能进行了研究。确定了 84 篇相关出版物。
根据“BIPED”分类对相关出版物的数据进行制表。将出版物中的个体分析总结为一般的“BIPED”评分。
生化标志物性能的评分分布不均,以及出版物之间的异质性使得难以直接比较单个生化标志物。因此,改为对生化标志物类别进行比较。一般来说,软骨降解的生化标志物的研究最广泛,与其他生化标志物类别相比表现良好。骨代谢的生化标志物表现不佳。滑膜组织代谢的生化标志物没有得到广泛研究,但表现相当好。
需要进一步研究特定的生化标志物和生化标志物类别,以及它们的性质、来源和代谢。应追求未来研究的国际标准化,以获得关于整个生化 OA 标志物范围的更多高质量、同质数据。